Evidence map›Paper›PMID 42144470›Full record

ReviewJournal of the Egyptian National Cancer Institute2026

Research status and challenges of anti-tumor effects of natural saponins and their combination therapy.

Can Cui, Zhou-Juan Zheng, Si Li, Xiang-Lan Piao

Abstract readReview
In one paragraph

Review in Journal of the Egyptian National Cancer Institute, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Can CuiSchool of Pharmacy, Minzu University of China, Beijing, China.
Zhou-Juan ZhengSchool of Pharmacy, Minzu University of China, Beijing, China.
Si LiSchool of Pharmacy, Minzu University of China, Beijing, China.
Xiang-Lan PiaoSchool of Pharmacy, Minzu University of China, Beijing, China. xlpiao@muc.edu.cn.

Funding

National Natural Science Foundation of China No. 82274209
6 · The paper itself

Abstract

Cancer is a leading global cause of death, and traditional chemotherapy is plagued by severe side effects, making the development of high-efficacy and low-toxicity antitumor agents an urgent need. Saponins, natural bioactive compounds, exhibit prominent antitumor potential. This review systematically retrieved relevant literature from 2015 to 2025 via Web of Science, PubMed and other databases, summarizing the antitumor effects and mechanisms of saponins, their synergistic value in combination with chemotherapy, as well as existing saponin-based drugs, translational challenges and corresponding solutions. Saponin monomers exert distinct antitumor efficacy, and their rational combination with chemotherapy yields notable advantages. Structural modification and dosage form optimization can effectively mitigate the inherent limitations of saponins. In conclusion, natural saponins hold great translational potential for antitumor therapy, and combination regimens represent a promising research focus in oncology treatment.

Indexed as

Antineoplastic AgentsAntineoplastic Agents, PhytogenicAntineoplastic Combined Chemotherapy ProtocolsNeoplasmsSaponinsAnimalsDrug SynergismHumansAntineoplastic AgentsAntineoplastic Agents, PhytogenicSaponinsAnti-tumorChemotherapy drugsCombination drugsSaponinsTraditional medicine

Identifiers

PMID42144470
PMCPMC13313304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.